IL160982A0 - Salts of 20(s)-camptothecin, processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

Salts of 20(s)-camptothecin, processes for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL160982A0
IL160982A0 IL16098202A IL16098202A IL160982A0 IL 160982 A0 IL160982 A0 IL 160982A0 IL 16098202 A IL16098202 A IL 16098202A IL 16098202 A IL16098202 A IL 16098202A IL 160982 A0 IL160982 A0 IL 160982A0
Authority
IL
Israel
Prior art keywords
sub
acid
sup
camptothecin
salts
Prior art date
Application number
IL16098202A
Other languages
English (en)
Original Assignee
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr filed Critical Reddys Lab Ltd Dr
Publication of IL160982A0 publication Critical patent/IL160982A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
IL16098202A 2001-09-25 2002-09-25 Salts of 20(s)-camptothecin, processes for the preparation thereof and pharmaceutical compositions containing the same IL160982A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN798MA2001 2001-09-25
PCT/IB2002/003950 WO2003027118A1 (en) 2001-09-25 2002-09-25 Pharmaceutically acceptable salts of 20(s)-camptothecins

Publications (1)

Publication Number Publication Date
IL160982A0 true IL160982A0 (en) 2004-08-31

Family

ID=33042623

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16098202A IL160982A0 (en) 2001-09-25 2002-09-25 Salts of 20(s)-camptothecin, processes for the preparation thereof and pharmaceutical compositions containing the same

Country Status (18)

Country Link
US (1) US7071203B2 (xx)
EP (1) EP1430059B1 (xx)
JP (1) JP2005507893A (xx)
KR (1) KR20040039404A (xx)
CN (1) CN1575292A (xx)
AT (1) ATE318823T1 (xx)
BR (1) BR0212990A (xx)
CA (1) CA2461089A1 (xx)
DE (1) DE60209517D1 (xx)
HU (1) HUP0401912A3 (xx)
IL (1) IL160982A0 (xx)
MX (1) MXPA04002784A (xx)
NO (1) NO20041643L (xx)
NZ (1) NZ531878A (xx)
PL (1) PL368229A1 (xx)
RU (1) RU2004109163A (xx)
WO (1) WO2003027118A1 (xx)
ZA (1) ZA200402321B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003207369A1 (en) * 2002-02-18 2003-09-04 Dr. Reddy's Laboratories Limited A process for the preparation of 10-hydroxy-9-n,n-dimethylaminomethyl-5-(2'-fluoroethoxy)-20(s)-camptothecin hydrochloride
TWI333492B (en) * 2003-11-12 2010-11-21 Smithkline Beecham Cork Ltd Crystalline topotecan hydrochloride product and preparation thereof
US7897772B2 (en) * 2004-10-01 2011-03-01 Kabushiki Kaisha Yakult Honsha Acid addition salt of irinotecan
ITMI20061473A1 (it) * 2006-07-26 2008-01-27 Indena Spa Derivati della camptotecina ad attivita antitumorale

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1025029C (zh) 1988-10-22 1994-06-15 沈阳药学院 喜树硷精氨酸盐制剂的制备方法
US6177439B1 (en) * 1995-06-06 2001-01-23 Reddy's Research Foundation Water soluble analogues of 20(S)-camptothecin
JP4094710B2 (ja) 1997-11-06 2008-06-04 株式会社ヤクルト本社 新規なカンプトテシン誘導体

Also Published As

Publication number Publication date
KR20040039404A (ko) 2004-05-10
EP1430059B1 (en) 2006-03-01
HUP0401912A2 (hu) 2005-01-28
WO2003027118A1 (en) 2003-04-03
NO20041643L (no) 2004-04-22
CA2461089A1 (en) 2003-04-03
ATE318823T1 (de) 2006-03-15
JP2005507893A (ja) 2005-03-24
US20040198760A1 (en) 2004-10-07
US7071203B2 (en) 2006-07-04
CN1575292A (zh) 2005-02-02
RU2004109163A (ru) 2005-10-10
MXPA04002784A (es) 2004-07-29
BR0212990A (pt) 2004-09-21
PL368229A1 (en) 2005-03-21
ZA200402321B (en) 2005-01-13
EP1430059A1 (en) 2004-06-23
NZ531878A (en) 2006-04-28
DE60209517D1 (de) 2006-04-27
HUP0401912A3 (en) 2007-02-28

Similar Documents

Publication Publication Date Title
HK1070649A1 (en) Quinoline derivative having azolyl group and quinazoline derivative
WO2003027050A3 (en) Process for preparing pentacene derivatives
CA2384283A1 (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
CA2289409A1 (en) Sulfoxide compounds and acetone complexes, and a process for producing the same
WO2001090097A3 (en) Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
CA2238875A1 (en) Tri-aryl ethane derivatives as pde iv inhibitors
WO2000064874A3 (en) Heterosubstituted pyridine derivatives as pde 4 inhibitors
AU8811401A (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
EA200100090A2 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
NO20051009L (no) Syntese av indoliziner
IL160982A0 (en) Salts of 20(s)-camptothecin, processes for the preparation thereof and pharmaceutical compositions containing the same
DE50304891D1 (de) N-aryl-4,5-diaminopyrazole und diese verbindungen enthaltende färbemittel
GB9930358D0 (en) Process for the preparation of chemical compounds
ATE397609T1 (de) Corticotropinfreisetzungsfaktor antagonisten
NO20053712L (no) Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
MXPA03011647A (es) Procedimiento de resolucion para el acido ( r ) - (-) - 2-hidroxi - 2- (2 - clorofenil) acetico.
EE200300090A (et) Asendatud imidasopüridiinühendite valmistamise meetod
NO20041551L (no) Substituerte alkylaminopyridazinonderivater, fremgangsmate til fremstilling derav og farmasoytisk sammensetning som inneholder dem
WO2002062798A3 (en) Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
AU2001259242A1 (en) Process for the preparation of chemical compounds
GB9906328D0 (en) 2-Substituted RNA preparation
GB0114699D0 (en) Organic compounds
AR036680A1 (es) Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol y compuestos utiles en su preparacion
CA2239053A1 (en) Diphenyl pyridyl ethane derivatives as pde iv inhibitors
NO20002497L (no) Fremgangsmåte for fremstilling av hydroksyforbindelser